25 May Trends in canine oncology
In a dvm360® interview, Sue Ettinger, DVM, DACVIM (Oncology), outlined the innovative tools currently being used in practice to address canine cancer
This video is sponsored by Jaguar Health.
During the Take C.H.A.R.G.E. event in New York City, Sue Ettinger, DVM, DACVIM (Oncology)—also known as “Dr Sue Cancer Vet”—sat down for a dvm360® interview accompanied by Lisa Conte, president, founder, and CEO of Jaguar Health. In this interview, Ettinger highlighted the latest diagnostic and treatment methods for dogs with cancer.
View the video below for the entire discussion. The following is a partial transcript.
Sue Ettinger, DVM, DACVIM (Oncology): It’s actually an exciting time to be an oncologist. We have new medications to alleviate side effects, so when we’re treating dogs with chemotherapy [these drugs] minimize the side effects . . . and I always say, ‘live longer, live well,’ if [the dog] is not tolerating treatment, we’re not doing our job.